Akebia Therapeutics, Inc. (AKBA)
1.46
+0.06
(+4.29%)
USD |
NASDAQ |
Mar 13, 16:00
1.465
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics EPS Diluted (Quarterly) : -0.0461 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1994 |
| MannKind Corp. | -0.0519 |
| Ligand Pharmaceuticals, Inc. | 2.119 |
| Ardelyx, Inc. | -0.0017 |
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.24M |
| Revenue (Quarterly) | 57.62M |
| Total Expenses (Quarterly) | 69.87M |
| Enterprise Value | 420.86M |
| Gross Profit Margin (Quarterly) | 77.69% |
| Profit Margin (Quarterly) | -21.25% |
| Earnings Yield | -1.23% |
| Operating Earnings Yield | 6.12% |
| Normalized Earnings Yield | -0.6918 |